Fiona E. Smyth

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

Andrew M. Scott, Fook-Thean Lee, Niall C. Tebbutt et al. · Proceedings of the National Academy of Sciences · 2007 · 217 citations

Life Sciences, Cancer Biology, Oncology +17

Adoptive transfer of T cells modified with a humanized chimeric receptor gene inhibits growth of Lewis-Y-expressing tumors in mice

Jennifer A. Westwood, Mark J. Smyth, Michele W.L. Teng et al. · Proceedings of the National Academy of Sciences · 2005 · 153 citations

Life Sciences, Immunology, Oncology +17

Novel monoclonal antibody specific for the de2‐7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene

Terrance G. Johns, Elisabeth Stockert, Gerd Ritter et al. · International Journal of Cancer · 2002 · 130 citations · Full text

Pharmacy, Cancer Biology, Oncology +17

A Phase I Trial of Humanized Monoclonal Antibody A33 in Patients with Colorectal Carcinoma: Biodistribution, Pharmacokinetics, and Quantitative Tumor Uptake

Andrew M. Scott, Fook-Thean Lee, Robert H. Jones et al. · Clinical Cancer Research · 2005 · 124 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +16

Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen

Stefan Peinert, H. Miles Prince, P Guru et al. · Gene Therapy · 2010 · 118 citations

Medicine, Immunology, Oncology +17